ESCMID Global: Maternal RSV vaccination cuts infant hospitalisation risk by over 80%, major UKHSA study finds

/PRNewswire/ — The largest real-world study of its kind, presented today atESCMID Global 2026, shows that maternal vaccination against respiratory syncytial virus (RSV) reduces the…

ESCMID Global: Maternal RSV vaccination reduces risk of infant hospitalization by more than 80%, according to major UKHSA study

/PRNewswire/ — Presented today at ESCMID Global 2026, the largest real-world study of its kind shows that maternal respiratory syncytial virus (RSV) vaccination reduces the…

ESCMID Global: RSV vaccination during pregnancy reduces the risk of hospitalization in infants by more than 80 percent, a large UKHSA study shows

/PRNewswire/ — The largest real-world study of its kind to date, presented today at ESCMID Global 2026, shows that RSV vaccination during pregnancy reduces the…